ArticleClinical pharmacokinetics2025

Population Pharmacokinetic and Pharmacodynamic Modelling and Simulation for Nedosiran Clinical Development and Dose Guidance in Pediatric Patients with Primary Hyperoxaluria Type 1.

Steven Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.